Entero Healthcare Solutions Limited (ENTERO.NS)
INR 1425.95
(-2.95%)
INR 1425.95
(-2.95%)
| Breakdown | 2024 | 2023 | 2022 | 2021 | 2020 |
|---|---|---|---|---|---|
| Operating Cash Flow | -366.12 Million | -453.15 Million | -352.66 Million | -686.84 Million | -365.18 Million |
| Net Income | 355.55 Million | -36.88 Million | -198.11 Million | -108.38 Million | 9.43 Million |
| Depreciation & Amortization | 250.17 Million | 242.37 Million | 197.54 Million | 162.76 Million | 114.42 Million |
| Deferred income taxes | - | - | - | - | - |
| Stock-based compensation | 17.67 Million | - | - | - | - |
| Change in working capital | -1.45 Billion | -1 Billion | -460.68 Million | -959.25 Million | -982.6 Million |
| Other non-cash items | 523.52 Million | 448.82 Million | 255.39 Million | 173.94 Million | 493.55 Million |
| Investing Cash Flow | -7.05 Billion | -485.95 Million | -1.61 Billion | -308.69 Million | -2.03 Billion |
| Investments in PPE | -54.16 Million | -55.19 Million | -98.66 Million | -95.29 Million | -449.53 Million |
| Acquisitions | -418.08 Million | -245.74 Million | -1.46 Billion | -10.99 Million | -1.58 Billion |
| Investment purchases | -6.68 Billion | -225.92 Million | - | - | - |
| Sales/Maturities of investments | - | - | - | - | - |
| Other Investing Activities | -6.57 Billion | -225.92 Million | -83.81 Million | -228.48 Million | -2.39 Million |
| Financing Cash Flow | 8.62 Billion | 727.64 Million | 2.11 Billion | 887.13 Million | 2.16 Billion |
| Debt repayment | -987.62 Million | -884.87 Million | -1.43 Billion | -352.34 Million | -29.15 Million |
| Dividends payments | - | - | - | - | - |
| Common Stock Repurchased | - | - | - | - | - |
| Common Stock Issuance | 10 Billion | 2.62 Million | 37.5 Million | - | - |
| Other Financing Activities | -660.93 Million | -489.72 Million | 766.5 Million | 577.11 Million | 2.19 Billion |
| Accounts receivables | -667.19 Million | -1.33 Billion | -682.19 Million | -119.19 Million | -570.64 Million |
| Accounts payables | 15.99 Million | - | - | - | - |
| Inventory | -581.83 Million | -193.94 Million | -300.97 Million | -489.51 Million | -388.71 Million |
| Other working capital | -224.23 Million | -48.29 Million | 337.3 Million | -260.73 Million | -23.24 Million |
| Cash at beginning of period | 253.62 Million | 465.08 Million | 323.14 Million | 431.54 Million | 661.43 Million |
| Cash at end of period | 1.47 Billion | 253.62 Million | 465.08 Million | 323.14 Million | 431.53 Million |
| Capital Expenditure | -54.16 Million | -55.19 Million | -98.66 Million | -95.29 Million | -449.53 Million |
| Effect of forex changes on cash | - | - | - | - | - |
| Net cash flow / Change in cash | 1.22 Billion | -211.46 Million | 141.94 Million | -108.4 Million | -229.89 Million |
| Free Cash Flow | -420.28 Million | -508.34 Million | -451.32 Million | -782.13 Million | -814.71 Million |
| Breakdown | 2023 FY | 2023 Q4 | 2023 Q3 | 2023 Q2 | 2023 Q1 | 2022 FY |
|---|---|---|---|---|---|---|
| Operating Cash Flow | - | - | - | - | - | - |
| Net Income | 355.55 Million | 216.57 Million | 67.77 Million | 56.82 Million | 56.82 Million | -36.88 Million |
| Depreciation & Amortization | 250.17 Million | - | - | 58.07 Million | 58.07 Million | 242.37 Million |
| Deferred income taxes | - | - | - | - | - | - |
| Stock-based compensation | 17.67 Million | 17.67 Million | - | 1.02 Million | 1.02 Million | - |
| Change in working capital | -1.45 Billion | - | - | -686.02 Million | -686.02 Million | -1 Billion |
| Other non-cash items | 523.52 Million | -234.24 Million | -67.77 Million | 156.5 Million | 156.5 Million | 448.82 Million |
| Investing Cash Flow | -7.05 Billion | - | - | -94.4 Million | -94.4 Million | -485.95 Million |
| Investments in PPE | -54.16 Million | - | - | -8.7 Million | -8.7 Million | -55.19 Million |
| Acquisitions | -418.08 Million | - | - | -116.37 Million | -116.37 Million | -245.74 Million |
| Investment purchases | -6.68 Billion | - | - | - | - | -225.92 Million |
| Sales/Maturities of investments | - | - | - | - | - | - |
| Other Investing Activities | -6.57 Billion | - | - | 30.67 Million | 30.67 Million | -225.92 Million |
| Financing Cash Flow | 8.62 Billion | - | - | 635.45 Million | 635.45 Million | 727.64 Million |
| Debt repayment | -987.62 Million | - | - | - | - | -884.87 Million |
| Dividends payments | - | - | - | - | - | - |
| Common Stock Repurchased | - | - | - | - | - | - |
| Common Stock Issuance | 10 Billion | - | - | - | - | 2.62 Million |
| Other Financing Activities | -660.93 Million | - | - | 635.45 Million | 635.45 Million | -489.72 Million |
| Accounts receivables | -667.19 Million | - | - | -490.73 Million | -490.73 Million | -1.33 Billion |
| Accounts payables | - | - | - | - | - | - |
| Inventory | -581.83 Million | - | - | -172.16 Million | -172.16 Million | -193.94 Million |
| Other working capital | -224.23 Million | - | - | -23.12 Million | -23.12 Million | -48.29 Million |
| Cash at beginning of period | 253.62 Million | - | - | - | - | 465.08 Million |
| Cash at end of period | 1.47 Billion | - | - | 127.44 Million | 127.44 Million | 253.62 Million |
| Capital Expenditure | -54.16 Million | - | - | -8.7 Million | -8.7 Million | -55.19 Million |
| Effect of forex changes on cash | - | - | - | - | - | - |
| Net cash flow / Change in cash | 1.22 Billion | - | - | 127.44 Million | 127.44 Million | -211.46 Million |
| Free Cash Flow | -420.28 Million | - | - | -422.31 Million | -422.31 Million | -508.34 Million |
2540
7914
1812
NPTVF
6981
PTEFF